Use of botulinum toxin A in management of children with cerebral palsy

被引:0
|
作者
Friedman, Bat-Chen [1 ]
Goldman, Ran D. [1 ]
机构
[1] BC Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada
关键词
INJECTIONS; SAFETY;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Question What is the role of intramuscular botulinum toxin injections in the management of spasticity and related morbidity in children with cerebral palsy? Answer When botulinum toxin A is injected into the limbs of children with spastic paresis, it induces temporary reduction in muscle tone. It also promotes better motor function when used in combination with conservative treatments such as physiotherapy. Although there is a growing body of evidence for its effective and safe treatment, there is still a lack of consensus on dose, treatment regimens, and the best integration with other clinical modalities.
引用
收藏
页码:1006 / 1073
页数:3
相关论文
共 50 条
  • [1] Botulinum Toxin in the Management of Children with Cerebral Palsy
    Multani, Iqbal
    Manji, Jamil
    Hastings-Ison, Tandy
    Khot, Abhay
    Graham, Kerr
    [J]. PEDIATRIC DRUGS, 2019, 21 (04) : 261 - 281
  • [2] Botulinum Toxin in the Management of Children with Cerebral Palsy
    Iqbal Multani
    Jamil Manji
    Tandy Hastings-Ison
    Abhay Khot
    Kerr Graham
    [J]. Pediatric Drugs, 2019, 21 : 261 - 281
  • [3] Use of botulinum toxin A in children with cerebral palsy
    Raftemo, Anne Elisabeth Ross
    Mahendran, Arani
    Hollung, Sandra Julsen
    Jahnsen, Reidun Birgitta
    Lydersen, Stian
    Vik, Torstein
    Andersen, Guro Lillemoen
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2019, 139 (08) : 713 - 717
  • [4] Comment on: “Botulinum Toxin in the Management of Children with Cerebral Palsy”
    Katherine Langdon
    Lisa Copeland
    Priya Edwards
    Kate Rodwell
    Kim McLennan
    Theresa Carroll
    Sasaka Bandaranayake
    Adam Scheinberg
    Mary-Clare Waugh
    Heather Burnett
    Neil Wimalasundera
    Sabine Hennel
    Eewei Lim
    Steve O’Flaherty
    [J]. Pediatric Drugs, 2019, 21 : 493 - 495
  • [5] Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy"
    Langdon, Katherine
    Copeland, Lisa
    Edwards, Priya
    Rodwell, Kate
    McLennan, Kim
    Carroll, Theresa
    Bandaranayake, Sasaka
    Scheinberg, Adam
    Waugh, Mary-Clare
    Burnett, Heather
    Wimalasundera, Neil
    Hennel, Sabine
    Lim, Eewei
    O'Flaherty, Steve
    [J]. PEDIATRIC DRUGS, 2019, 21 (06) : 493 - 495
  • [6] Botulinum toxin management of esotropia in children with cerebral palsy
    Vinciguerra, A
    Pensiero, S
    Cordaro, C
    Perissutti, P
    Carlentini, S
    [J]. TRANSACTIONS: 27TH MEETING OF THE EUROPEAN STRABISMOLOGICAL ASSOCIATION, 2001, : 387 - 390
  • [7] Use of botulinum toxin type A in children with cerebral palsy
    Nolan, KW
    Cole, LL
    Tak, GSL
    [J]. PHYSICAL THERAPY, 2006, 86 (04): : 573 - 584
  • [8] Use of botulinum toxin in 55 children with cerebral palsy
    Mohammadi, M
    [J]. CEREBRAL PALSY AT THE TURN OF THE MILLENNIUM, 2001, : 105 - 112
  • [9] USE AND ADVERSE EFFECTS OF BOTULINUM TOXIN IN MANAGEMENT OF CHILDREN WITH SPASTIC CEREBRAL PALSY
    Ulici, Alexandru
    Sterian, Alin-Gabriel
    Tevanov, Iulia
    Popescu, Mihai-Bogdan
    [J]. FARMACIA, 2017, 65 (03) : 454 - 459
  • [10] Botulinum toxin in children with cerebral palsy
    Singhi P.
    Ray M.
    [J]. The Indian Journal of Pediatrics, 2004, 71 (12) : 1087 - 1091